Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Bristol Myers Squibb

Bristol Myers Squibb (NYSE: BMY) insider transactions

In the twelve months to 10 November 2026, executives and directors of Bristol Myers Squibb reported 5 open-market sales of 40,549 shares ($2.5m) and 0 open-market purchases, by 4 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Bristol Myers Squibb shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
5 November 2026Haller Julia ADirectorOpen-market sale−3,800$63.3130,279Form 4
3 November 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise+7,522—27,228Form 4
3 November 2026Lenkowsky AdamEVP, Chief Commercial OfficerShares withheld for tax−3,848$61.7123,380Form 4
1 November 2026Boerner Christopher S.Chief Executive OfficerOption exercise+2,964—24,415Form 4
1 November 2026Boerner Christopher S.Chief Executive OfficerOther+406—24,821Form 4
1 November 2026Boerner Christopher S.Chief Executive OfficerShares withheld for tax−1,724$62.4823,097Form 4
1 November 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Option exercise+6,281—36,642Form 4
1 November 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Shares withheld for tax−2,665$62.4833,977Form 4
1 November 2026Shanahan KarinEVP, Chief Supply Chain & OpsOption exercise+6,281—32,169Form 4
1 November 2026Shanahan KarinEVP, Chief Supply Chain & OpsShares withheld for tax−3,213$62.4828,956Form 4
2 October 2026Gallman CariEVP, General CounselOption exercise+4,559—18,208Form 4
2 October 2026Gallman CariEVP, General CounselShares withheld for tax−2,332$61.1515,876Form 4
9 September 2026Massacesi CristianEVP,Chief Med Offr,Head of DevOpen-market sale−6,249$64.5718,748Form 4
1 September 2026Short Bartie WendyEVP, Corporate AffairsOption exercise+1,236$66.9213,317Form 4
1 September 2026Short Bartie WendyEVP, Corporate AffairsShares withheld for tax−633$66.9212,684Form 4
25 August 2026Holzer Phil MSVP and ControllerOpen-market sale−500$67.5016,862Form 4
1 August 2026Gallman CariEVP, General CounselOption exercise+1,061—14,192Form 4
1 August 2026Gallman CariEVP, General CounselShares withheld for tax−543$65.3113,649Form 4
1 August 2026Massacesi CristianEVP,Chief Med Offr,Head of DevOption exercise+51,172—51,172Form 4
1 August 2026Massacesi CristianEVP,Chief Med Offr,Head of DevShares withheld for tax−26,175$65.3124,997Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Bristol Myers Squibb page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.